Pages that link to "Q35630861"
Jump to navigation
Jump to search
The following pages link to Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function (Q35630861):
Displaying 30 items.
- High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions (Q33616618) (← links)
- Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent (Q36192977) (← links)
- Gestational exercise protects adult male offspring from high-fat diet-induced hepatic steatosis. (Q36405082) (← links)
- Endothelial Estrogen Receptor-α Does Not Protect Against Vascular Stiffness Induced by Western Diet in Female Mice. (Q36753822) (← links)
- The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities (Q37024780) (← links)
- Linagliptin alleviates fatty liver disease in diabetic db/db mice (Q37411528) (← links)
- Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice. (Q37628330) (← links)
- Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes (Q37676824) (← links)
- Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance (Q38760082) (← links)
- Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). (Q39044073) (← links)
- Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. (Q39103371) (← links)
- Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide? (Q41983713) (← links)
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease (Q42377919) (← links)
- Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide (Q46074650) (← links)
- Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes. (Q47603611) (← links)
- Peroxisome proliferator-activated receptor-α accelerates α-chlorofatty acid catabolism (Q49367354) (← links)
- Difference between observed and predicted glycated hemoglobin at baseline and treatment response to vildagliptin-based dual oral therapy in patients with type 2 diabetes (Q49997164) (← links)
- Developmental origins of non-alcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. (Q50420689) (← links)
- The protein and neutral lipid composition of lipid droplets isolated from the fission yeast, Schizosaccharomyces pombe (Q51030102) (← links)
- Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice (Q51285414) (← links)
- Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models (Q51304729) (← links)
- Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet. (Q55253186) (← links)
- Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice (Q64077617) (← links)
- Alogliptin improves survival and health of mice on a high-fat diet (Q64261538) (← links)
- From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options (Q89624033) (← links)
- Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes (Q90044484) (← links)
- Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects (Q92860558) (← links)
- Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System (Q93164933) (← links)
- Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism (Q93187889) (← links)
- Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds (Q93212669) (← links)